Cite
HARVARD Citation
Satoh, T. et al. (n.d.). 617PDA phase III study of nivolumab (nivo) in previously treated advanced gastric or gastric esophageal junction (G/GEJ) cancer (ATTRACTION-2): Two-years update data. Annals of oncology. p. . [Online].